{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:41:18Z","timestamp":1781782878255,"version":"3.54.5"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ajp.2023.103460","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T13:07:40Z","timestamp":1673269660000},"page":"103460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The potential of vortioxetine in treating obsessive-compulsive disorder"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6559-280X","authenticated-orcid":false,"given":"Tathagata","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2023.103460_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211034320","article-title":"Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update","volume":"11","author":"Adamo","year":"2021","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.ajp.2023.103460_bib2","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2023.103460_bib3","first-page":"36","article-title":"Vortioxetine (Brintellix): a new serotonergic antidepressant","volume":"40","author":"D\u2019Agostino","year":"2015","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.ajp.2023.103460_bib4","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/JCP.0000000000000801","article-title":"Vortioxetine and aripiprazole combination in treatment-resistant obsessive-compulsive disorder: a case report","volume":"37","author":"De Berardis","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2023.103460_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1017\/S1092852921000080","article-title":"Poor man\u2019s vortioxetine","volume":"27","author":"Feinberg","year":"2022","journal-title":"CNS Spectr."},{"key":"10.1016\/j.ajp.2023.103460_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1176\/appi.ajp.2020.20111601","article-title":"Harmonizing the neurobiology and treatment of obsessive-compulsive disorder","volume":"178","author":"Goodman","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103460_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5005\/jp-journals-10067-0059","article-title":"A \u201cReal-World\u201d chart review study of monotherapy and adjunctive vortioxetine in clinical practice","volume":"14","author":"Karia","year":"2020","journal-title":"Indian J. Priv. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103460_bib8","article-title":"Successful vortioxetine monotherapy for an adolescent with treatment-resistant obsessive-compulsive disorder","volume":"26","author":"Naguy","year":"2019","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.ajp.2023.103460_bib9","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.4103\/0019-5545.196976","article-title":"Clinical practice guidelines for obsessive-compulsive disorder","volume":"59","author":"Reddy","year":"2017","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103460_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102642","article-title":"Naturalistic outcome of medication-na\u00efve obsessive compulsive disorder treated with serotonin reuptake inhibitors","volume":"60","author":"Thamby","year":"2021","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103460_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102625","article-title":"Transcranial direct current stimulation for treatment-resistant obsessive-compulsive disorder\u2014A large case series","volume":"60","author":"Thamby","year":"2021","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103460_bib12","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.2174\/1389450118666171117131151","article-title":"Vortioxetine treatment for anxiety disorder: a meta-analysis study","volume":"19","author":"Yee","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ajp.2023.103460_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12991-021-00340-8","article-title":"Major depression with musical obsession treated with vortioxetine: a case report","volume":"20","author":"Yoshimura","year":"2021","journal-title":"Ann. Gen. Psychiatry"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187620182300014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187620182300014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:47:55Z","timestamp":1761756475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187620182300014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":13,"alternative-id":["S187620182300014X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2023.103460","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of vortioxetine in treating obsessive-compulsive disorder","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2023.103460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103460"}}